Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
See blue --->>> Aleafia Health increases bought deal offering to $20M • 9:38 AM
Aleafia Health (OTCQX:ALEAF) agreed to increase the size of its earlier announced bought deal units offering; udnerwriters agreed to purchase 24M units at $0.83/unit for gross proceeds of $19.92M.
Each Unit will be comprised of one common share and one-half of one Common Share purchase warrant; each warrant enables holder to purchase one share at $1.05 for 2 years post offer close (Mar.9).
Underwriters granted over-allotment option of purchasing additional 15% of the units; if option fully exercised, the company will receive an additional $2.99M.
Proceeds to be used for general corporate purposes.
Today's PPS beat down is a direct correlation to the fundraising. The silver lining is they will still be better capitalized, and the $25M cash repayment still keeps in place the annual $2M interest savings. IMO, on balance Aleafia is better off today than a month ago. - FUNMAN
Its over worth and dilution has already transferred so its retail that is dumping if anything. Where will these guys sell the shares?
--The Company has agreed to grant the Underwriter an over-allotment option (the "Over-Allotment Option"), solely for market stabilization and overallocation purposes, to purchase up to an additional 15% of the Units at the Issue Price, exercisable in whole or in part, at any time on or prior to the date that is 30 days following the closing of the Offering. If this option is exercised in full, the Company will receive an additional $2,241,000 in gross proceeds for total aggregate gross proceeds of $17,181,000.
-- Each Warrant shall entitle the holder thereof to purchase one Common Share at an exercise price of $1.05, for a period of 24 months following the closing of the Offering.
Maybe there is a reason they announced this mornings New first and then this News tonight, they may be using the cash flow for the Facility announce this Morning and a few more may be coming.. JMHO.
I expect a Very good Q-4, with some better visibility on the Unifor deal, which I feel has been over-Looked at the current share Price. The full Picture will be much Clearer once they Report, I can't see this drop into the 40's or low 50's and if it does I'll load UP... Good Day..
In perfect world you are correct however with bunch of picks shorting this stock we might end up going low again. Don’t get me wrong. I’ve been a holder since Emblem days. Haven’t recovered nearly half in 3.5 years. I don’t understand why are we doing that. At least wait till earnings to give shareholders a better picture prior doing this.
Yeah i just dont know here... This was bought in the 80s. 17,000,000$ total in proceeds. You think that was oversubscribed for the price to drop for six months? I do think the price surpresses but i really dont see it going to the 40s or even 50s USD i see this holding up well actually. But i do see about a ten cent drop to the bought deal price in efforts to gain more shares at the prices.
It will be a huge dump tomorrow and we will never make it to 80’s for another 6 months. I don’t understand why they do this type of sh@&. You can’t built shareholders trust the way they are conducting the business. Geeezzzz!!’
Yes what i was askin was your thoughts on the 18,000,000 units not $$. bought deal offering at .83 and if it would surpress the stock until it closes? The price here to me remains unaffected froma buy rating yet might see it stay down for a few weeks. The large pull back has already taken place here. I was talking aleaf.
Aphria Shareholders will receive 0.8381 shares of Tilray.
Only you may know what you typed and what you are asking me?
Tomorrow may kill the PPS if Tilray disappoints. Same if REDDIT did get involved again.
I should have sold my Aphria at $32 like a friend did but I thought it might fly for one more day. I was wrong and greedy even though I knew what was happening. Geeezzz even CNBC was talking about it all day.
The combined companies' fundamentals don't equate to the current PPS's. They don't make money. Eventually investors are going to notice and care.
Having bought in the $4's I'm not a buyer interested in raising my cost basis. I was going to be excited if Aphria hit $11.
The combined companies may be the first to breach the $1B mark. That's going to be exciting.
Tilray was saved by the deal. Simon has to find the $100M in synergies otherwise the PPS will be punished.
Once they start posting profitable quarterly EPS's don't you think The Street will give it a multiple P/E valuation? If so, the current PPS's are way overvalued. The Sweetwater acquisition is the Aphria linchpin meaning USA legalization allowing interstate THC beverage commerce HAS to happen to capitalize on the USA to justify the PPS.
Profits from the EU are still over the horizon. They are moving to rec legal a lot slower than the USA.
So right now, a lot hangs in the balance with a lot of "ifs".
So your take here? Selling and buying after the deal is closed?? Holding?? Should this be affected much beings it’s an 18,000,000$ investment at .82? - 'xray168'
We knew it had to be coming (see red). --->>> Aleafia Health Announces $15 Million Bought Deal Offering of Units
All of the great things the company is doing costs money. They had to recapitalize after announcing the full repayment of $25M in cash of its 8% unsecured convertible debt. This is just another reason why I believe the revenues will look great, but the net will still be red.
Come on Aleafia; convert the lowest all-in cost per gram in the industry into profits already! - FUNMAN
Aleafia Health Inc. Tue, February 16, 2021, 4:17 PM·5 min read
TORONTO, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has entered into an agreement with Cantor Fitzgerald Canada Corporation, as lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters (together, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase 18,000,000 units of the Company (the “Units”), on a “bought deal” basis pursuant to a short form prospectus offering, subject to all required regulatory approvals, at a price per Unit of $0.83 (the “Issue Price”) for gross proceeds of $14,940,000 (the “Offering”).
Each Unit will be comprised of one common share in the capital of the Company (a “Common Share”) and one-half of one common share purchase warrant (each whole warrant, a “Warrant”). Each Warrant shall entitle the holder thereof to purchase one Common Share at an exercise price of $1.05, for a period of 24 months following the closing of the Offering.
The Company has agreed to grant the Underwriter an over-allotment option (the “Over-Allotment Option”), solely for market stabilization and overallocation purposes, to purchase up to an additional 15% of the Units at the Issue Price, exercisable in whole or in part, at any time on or prior to the date that is 30 days following the closing of the Offering. If this option is exercised in full, the Company will receive an additional $2,241,000 in gross proceeds for total aggregate gross proceeds of $17,181,000.
In connection with the Offering the Company has agreed to pay the Underwriters a cash fee of 7% of the aggregate gross proceeds raised from the Offering, and non-transferable compensation warrants equal to 6% of the Units sold under the Offering (in each case including any exercise of the Over-Allotment Option).
The Company intends to use the net proceeds of the Offering for working capital and general corporate purposes.
The closing date of the Offering is scheduled to be on or about March 9, 2021 and is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the approval of the Toronto Stock Exchange and the applicable securities regulatory authorities.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws.
For Investor & Media Relations
Nicholas Bergamini, VP Investor Relations 1-833-TSX-ALEF (879-2533) IR@AleafiaHealth.com
Learn More
www.AleafiaHealth.com
About Aleafia Health
Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.
Aleafia Health owns three significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, edibles, sublingual strips and vapes. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.
Forward Looking Information
This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
With all the new PR’s and everything g else brewing why can’t this stock hold the water. All other pot stocks are mooning! I just can understand how suck a solid company can’t take off.
Great news! See Blue for impact --->>> Aleafia Health Secures Licence for Toronto Distribution Centre, Expanding Supply Chain and Ecommerce Opportunity
I follow a lot of Cannabis companies and have not heard about some of the groundwork Aleafia has, and continues to put in place.
Plans for direct shipments to retailers reminds me of how in the USA surrounding certain airports, it was a tremendous economic stimulus for the companies that opened facilities near the airports. Toronto is a big airline HUB. Just as DFW (Dallas - Fort Worth) was a huge boost for companies that opened facilities nearby, Aleafia should strongly benefit from this move. See some more of the reasons highlighted below. - FUNMAN
TORONTO, February 16, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) today announced its wholly owned subsidiary Emblem Cannabis Corporation has received a Health Canada Processing Licence (the “Licence”) for its new Distribution Centre (the “DC”). Located minutes from Toronto Pearson International Airport, the DC greatly strengthens the Company’s downstream supply chain, allowing for immediate expansion of same day delivery service, and eventual direct-to-retailer cannabis distribution.
Launched in April 2020, the Company’s AssureHome Delivery has provided patients in the Greater Toronto Area (“GTA”) and surrounding communities with same day cannabis delivery, for orders made by noon on any business day. With the new DC, the Company intends to significantly expand this service. This includes later order cutoff times, weekend and after-hours deliveries, and an enlarged service area. Additionally, it will allow for more efficient order fulfilment of adult-use shipments to provincial government wholesalers.
Located in Vaughan, a suburb of Toronto, the DC is within a two-hour drive of nine million people, or 25 per cent of the Canadian population. Due to this proximity, the Company expects to be able to continue to expand market share in the medical cannabis market.
“COVID-19 has resulted in a rapid expansion in ecommerce, coupled with greater demand for same-day delivery. Yet while supply chain logistics is among the most important cannabis industry competencies, it is also the least developed,” said Aleafia Health CEO Geoffrey Benic. “We plan to capitalize on this through a continued expansion of our AssureHome Delivery platform, which allows us to offer our customers and patients what they want, when they want it.”
The DC builds upon Aleafia Health’s existing production supply chain, which features two low-cost cultivation facilities and a value-added extraction and manufacturing site, all of which surround the GTA. The Licence was granted on February 12, 2021, expires on February 12, 2024, and authorizes cannabis storage and the fulfilment of orders to other licence holders, medical patients, adult-use provincial wholesalers and international customers.
Geoffrey Benic and Chief Operating Officer Greg Rossi were among the founding team members of the award-winning online grocery fulfillment and delivery service, GroceryGateway.com. The pair have also worked as executive consultants on supply chain logistics projects for some of the world’s largest companies including Walmart Inc., Nestlé S.A., Kraft Heinz Company, Campbell Soup Company and Mondelez International.
For Investor & Media Relations:
Nicholas Bergamini, VP Investor Relations 1-833-879-2533 IR@AleafiaHealth.com LEARN MORE: www.AleafiaHealth.com
About Aleafia Health:
Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.
Aleafia Health owns four significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, edibles, sublingual strips and vapes. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.
Forward Looking Information
This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities including the expansion of same-day delivery service to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Just wondering how much did this building cost, how large is it, and has it already been paid for? Will they expand into other provinces, BC or Quebec? Keep the good news coming...
The analyst’s bias works in our favour lol! I love it when they are bound by arbitrary restriction from looking at other companies with bigger upside short term. These experts use in accurate metrics to evaluate something they have never seen before. I am delighted I am not bound by anything but my own knowledge of the space and how it has rolled out since its inception :) They make no mention of the progress made by small, soon to be very large, companies like Aleafia. They can stay off the expert’s radar for longer yet! I need more shares!
That certainly is the golden ticket. Those folks are brilliant. I love the fact it will save the insurers in the long run too! It is a win all the way around. The workers actually get to be well without addiction, they do not have to choose between rent and medicine and the company will save large on the medication and productivity. My requirement for only making money by making the world better is met :) Happy Happy glass here lol!
Aleaf, is as solid as it can be. international sales in, Israel, Aleafia Germany (Acnos Pharmacy) 60% Aleaf shipments started in Sept. 2020, Three year Agreement with Equinox Pharmaceutical, shipments to Apipharm Europe, Shipments to Australia cannabis extract (Second shipment).
Now Unifor Deal signed 10 agreement, along with all the New Products and in up-to 93% retail in Canada. Bring on the Q-4 and the 25 Million Debt. they just paid for... This Company is going to Erupt. Good day.. Yes I will add to my Shares..
That is a very good strategy. I do not think there is such a thing as too many shares in a good company and in my opinion this is the best cdn lp I have 10,000 here my main buys are in some equally small but mighty US producers.
TORONTO, February 11, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch of its new Canadian cannabis portfolio Sunday Market. Under the Sunday Market family are four new distinct brands, each tailored to a specific consumer segment and featuring its own roster of cannabis products.
The four brands will be launched in the adult-use market, with some formats also being made available to patients of Aleafia Health’s medical cannabis subsidiary, Emblem. They will complement Aleafia Health’s existing Symbl adult-use brand and Kin Slips sublingual strips line of products.
“The Sunday Market house of brands has been crafted to provide consumers with a welcoming, authentic experience that showcases the local community and the people that create great cannabis products,” said Tricia Symmes, Aleafia Health’s chief commercial officer. “Our well-earned reputation for product quality and excellence serves as the foundation for the launch of these new highly differentiated brands and an expanding product portfolio.”
Nith & Grand: The flagship brand’s namesake is a tribute to our product innovation facility’s home community of Paris, Ont., whose scenic downtown core is centred around the confluence of the Nith and Grand rivers. Featuring hang dried, hand trimmed, small batch dried flower, and premium concentrates, Nith & Grand appeals to cannabis aficionados with discerning tastes. First products launch in Q2 2021. Bogart’s Kitchen: An edible cannabis brand, Bogart’s Kitchen combines extensive R&D and culinary experimentation to provide novice and high frequency cannabis consumers with a craveable experience. It will feature high demand formats including soft chews, along with some novel edibles not yet available in Canada. First products will appear in Q1 2021. Divvy: The friendly, everyday cannabis brand, Divvy will feature affordable, high-quality, dried flower, pre-rolls, vape cartridges and concentrates, including larger format SKUs. First products are expected to appear in Q1 or early Q2 2021. Noon & Night: The trailblazing Noon & Night is a cannabis wellness brand, catering to the growing demand for CBD-dominant products in both traditional CPG and other more innovative formats. It will feature innovative formats that are already an important component of consumers’ everyday wellness routine. First products launching in Q2 2021. For Investor & Media Relations:
Nicholas Bergamini, VP Investor Relations 1-833-879-2533 IR@AleafiaHealth.com LEARN MORE: www.AleafiaHealth.com
About Aleafia Health:
Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.
Aleafia Health owns three significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, edibles, sublingual strips and vapes. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.
Forward Looking Information
This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
News 
Market Data 
Discover 
AI
